Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol vs Salmeterol on Small Airways in COPD
NCT01344655Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Apr 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of formoterol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Respiratory Impedance by Impulse oscillometry. Started Apr 2011; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01344655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344655.